You have 9 free searches left this month | for more free features.

Vatalanib

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor Trial in Los Angeles (warfarin)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Aug 3, 2020

Solid Tumor Trial in Rochester (drug, other, procedure)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • vatalanib
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 4, 2019

Brain and CNS Tumors, Sarcoma Trial in Chicago, Seattle (vatalanib)

Completed
  • Brain and Central Nervous System Tumors
  • Sarcoma
  • vatalanib
  • Chicago, Illinois
  • +2 more
Oct 24, 2018

Melanoma Trial in Germany (PTK787/ZK 222584, Dacarbazine)

Terminated
  • Melanoma
  • Essen, Germany
  • +3 more
Sep 28, 2021

Colorectal Tumors, Colonic Tumors, Rectal Tumors Trial in Worldwide (Vatalanib)

Completed
  • Colorectal Neoplasms
  • +2 more
  • Vatalanib
  • Birmingham, Alabama
  • +222 more
Feb 6, 2020

Ovarian Cancer, Endometrial Cancer, Cervical Cancer Trial in Boston (Docetaxel, PTK787)

Completed
  • Ovarian Cancer
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jul 26, 2018

Angiogenesis and Disease in Unresectable Malignant Mesothelioma

Terminated
  • Malignant Mesothelioma
  • immunoenzyme technique
  • laboratory biomarker analysis
  • (no location specified)
Jan 22, 2019

Osteosarcoma, Metastasis Trial in Beijing (apatinib)

Completed
  • Osteosarcoma
  • Metastasis
  • Beijing, Beijing, China
    Peking University People's Hospital
Apr 19, 2018

Gastric Cancer, Hepatocellular Carcinoma Trial in Beijing (apatinib, SHR-1210)

Unknown status
  • Gastric Cancer
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    The Affiliated Hospital of the Chinese Academy of Military Medic
Feb 23, 2018

Kidney Cancer, Solid Tumor Trial in Durham (RAD001 (everolimus), PTK787 (vatalanib))

Completed
  • Kidney Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
  • RAD001 (everolimus)
  • PTK787 (vatalanib)
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Mar 1, 2016

Colorectal Tumors, Colonic Tumors, Rectal Tumors Trial in Worldwide (Vatalanib)

Completed
  • Colorectal Neoplasms
  • +2 more
  • Vatalanib
  • Huntsville, Alabama
  • +250 more
Mar 2, 2017

Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in United States (vatalanib)

Completed
  • Leukemia
  • +2 more
  • vatalanib
  • Lewes, Delaware
  • +67 more
Jul 1, 2016

Gastrointestinal Carcinoid Tumor, Islet Cell Carcinoma Trial (octreotide acetate, vatalanib, anti-cytokine therapy)

Withdrawn
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Carcinoma
  • octreotide acetate
  • +10 more
  • (no location specified)
Oct 6, 2015

Brain and CNS Tumors Trial in Durham (hydroxyurea, imatinib mesylate, vatalanib)

Completed
  • Brain and Central Nervous System Tumors
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Oct 11, 2015

Von Hippel-Lindau Disease, CNS Hemangioblastoma, Retinal Hemangioblastoma Trial in Boston, Durham (PTK787/ZK 222584)

Completed
  • Von Hippel-Lindau Disease
  • +2 more
  • PTK787/ZK 222584
  • Boston, Massachusetts
  • +1 more
Mar 2, 2017

Malignant Mesothelioma Trial in United States (PTK787/ZK 222584)

Completed
  • Malignant Mesothelioma
  • PTK787/ZK 222584
  • Anniston, Alabama
  • +79 more
Jun 30, 2016

Esophageal Cancer, Metastatic Esophageal Cancer, Apatinib Trial in Hangzhou (Apatinib)

Unknown status
  • Esophageal Cancer
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou Cancer Hospital
Aug 25, 2016

Pancreatic Cancer Trial in Stanford (Vatalanib, Gemcitabine)

Completed
  • Pancreatic Cancer
  • Stanford, California
    Stanford University School of Medicine
Sep 10, 2014

Lymphoma, Large-Cell, Diffuse Trial in Chapel Hill, Columbia, Durham (PTK787)

Terminated
  • Lymphoma, Large-Cell, Diffuse
  • Chapel Hill, North Carolina
  • +2 more
Nov 19, 2014

Breast Cancer Trial in United States (PTK787, Trastuzumab)

Terminated
  • Breast Cancer
  • Elkhart, Indiana
  • +7 more
Dec 8, 2015

Prostate Cancer Trial (PTK787)

Completed
  • Prostate Cancer
  • (no location specified)
Jan 15, 2015

Non Small Cell Lung Cancer Trial in France, Germany (SH T00268C, PTK787/ ZK 222584)

Completed
  • Non Small Cell Lung Cancer
  • SH T00268C
  • PTK787/ ZK 222584
  • Paris, France
  • +5 more
Dec 14, 2014

Tumor Metastasis, Carcinoma Trial in Indianapolis (Paclitaxel plus PTK787)

Completed
  • Neoplasm Metastasis
  • Carcinoma
  • Paclitaxel plus PTK787
  • Indianapolis, Indiana
    Indiana University Simon Cancer Center
Sep 10, 2014

Melanoma (Skin) Trial in Cambridge, Leicester (vatalanib)

Completed
  • Melanoma (Skin)
  • vatalanib
  • Cambridge, England, United Kingdom
  • +1 more
Aug 1, 2013

Multiple Myeloma Trial in St. Louis (PTK787/ZK 222584)

Terminated
  • Multiple Myeloma
  • PTK787/ZK 222584
  • St. Louis, Missouri
    Washington University School of Medicine
Sep 5, 2014